
Cost-utility analysis of palivizumab in Italy: results from a simulation model in the prophylaxis of respiratory syncytial virus infection (RSV) among high-risk preterm infants
Gaetano Chirico, Roberto Ravasio, Urbano SbarigiaVolume:
35
Langue:
english
DOI:
10.1186/1824-7288-35-4
Date:
December, 2009
Fichier:
PDF, 984 KB
english, 2009